Pharmafile Logo
Pharmafocus logo
Advanced Search
Georg Toufar

Working Life: Georg Toufar, director, Mundipharma

February 21, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Georg Toufar, Mundipharma, Working Life

Georg Toufar is director of European marketing and sales and member of the executive committee at Mundipharma International Limited (MINT).  …

Feature

Bayer eye drug succeeds in long-term study

February 21, 2012
Research and Development, Sales and Marketing Bayer, Lucentis, aflibercept, wet AMD

Bayer’s eye drug aflibercept has succeeded in a long-term study in patients with a common eye condition.  The Phase III …

News
Teva image

MHRA suspends Teva licence for levothyroxine generic

February 21, 2012
Manufacturing and Production MHRA, Numark, Teva, levothyroxine

The UK medicine regulatory authority has suspended the licence for a levothyroxine product sold by Teva on the grounds that …

News

Contract research news in brief

February 21, 2012
Research and Development Almac, GVK Biosciences and PreClinOmics/AIT, PPD, Quintiles

Our round-up of news from the contract research sector includes PPD’s sales to a private equity consortium, new clinical supply …

News

Asymchem plans additional investment in Dunhua facility

February 21, 2012
Manufacturing and Production Asymchem, China, Dunhua, manufacturing

China’s Asymchem Laboratories says it plans to invest another $12 million in its recently-opened manufacturing facility in Dunhua, Jilin province, …

News

Setback for Gilead hep C candidate

February 20, 2012
Research and Development, Sales and Marketing ELECTRON, GS-7977, Gilead, Pharmasset

Gilead’s investigational hepatitis C drug has been dealt a blow after patients suffer relapses in a mid-stage trial.  In the …

News

Shortages likely as Sandoz’s Canadian plant woes continue

February 20, 2012
Manufacturing and Production FDA, Novartis, Sandoz

Ongoing compliance problems at a plant in Canada operated by Novartis’ generics subsidiary Sandoz look set to cause supply disruptions …

News

Pfizer closes in on $545m China generics deal

February 20, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing China, Hisun, Pfizer, Zhejiang, generics

Pfizer has moved a step closer to a deal with Shanghai-based Zhejiang Hisun Pharmaceutical to develop generic drugs in China.  …

News

Health Information appoints Nigel Brooksby as its deputy chairman

February 20, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Brooksby, Health Information

Health Information, a provider of medicine adherence services in the UK, has appointed former ABPI president Nigel Brooksby as its …

Appointment
Zelboraf image

European approval for Roche’s Zelboraf

February 20, 2012
Sales and Marketing Cancer, Roche, Yervoy, Zelboraf, melanoma

Roche’s skin cancer pill Zelboraf has been given European approval to treat advanced melanoma.  Zelboraf (vemurafenib) is now available in …

News
Tyverb picture

GSK pulls Tyverb extension in Europe

February 17, 2012
Sales and Marketing GSK, Herceptin, Tyverb, Xeloda

GlaxoSmithKline has withdrawn its European application to extend the licence of its breast cancer pill Tyverb. The firm was seeking …

News
UCB image

UCB releases ‘Epilepsy In Our Time’ video diaries

February 17, 2012
Medical Communications UCB, epilepsy

UCB has released Epilepsy In Our Time, a video diary that explores life with epilepsy from the perspective of those …

News

Life tops up its team with two new appointments

February 17, 2012
Medical Communications Life healthcare communications

 Life Healthcare Communications has made two new appointments, growing its client service and production departments. Matt Leeming joins Life as …

News
Tarceva image

NICE no for first line Tarceva

February 17, 2012
Sales and Marketing CDF, Cancer, NICE, Roche, Tarceva

NICE no for first line Tarceva Watchdog wants more information on Roche’s drug NICE is not recommending Roche’s lung cancer …

News
Merck image

Merck unveils Brazilian joint venture

February 17, 2012
Sales and Marketing Brazil, Merck & Co, Supera Farma, emerging markets

Merck Inc has bolstered its presence in emerging markets by entering a joint venture with Brazilian firm Supera Farma Laboratorios. Due …

News

Cimzia results excite UCB in psoriatic arthritis

February 16, 2012
Research and Development, Sales and Marketing Cimzia, UCB, psoriatic arthritis

UCB will submit Cimzia for psoriatic arthritis by the end of 2012, after positive Phase III trial results for the …

News

Words – the most powerful drug

February 16, 2012
Medical Communications

 Why good internal communication within organisations is essential in these fraught timesBy William Hind, Founder – AlpharmaximThe precise quote by …

Feature
Thought Leadership

Panu Miettinen appointed chief financial officer of Biotie

February 16, 2012
Business Services, Research and Development, Sales and Marketing Biotie, Panu Miettinen

Panu Miettinen, 43, has been appointed chief financial officer of Biotie Therapies.  He will become a member of the Group’s …

Appointment
lucverhelst

EMA appoints new head of information and communications technology

February 16, 2012
Business Services, Medical Communications, Sales and Marketing EMA, Luc Verhelst

Luc Verhelst has been appointed as the new head of the European Medicines Agency’s information and communications technology unit. Verhelst …

Appointment

MRN launches online training portal

February 16, 2012
Research and Development

16 February 2012 – Medical Research Network (MRN), the unique Clinical Trial Support Organisation (CTSO) offering home trial support, site …

News
Press release
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026